Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.49 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.49 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.44 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 8/20 | 0.38 |
| ▸ | MAOA | P21397 | 8/20 | 0.38 |
| ▸ | MAOB | P27338 | 8/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7108506 | 1.00 | CHRM2 (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL31337060 | 0.86 | KDM1A (0.45) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL19809223 | 0.86 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL14297804 | 0.81 | CHRM2 (0.40) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL19809197 | 0.81 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL19809362 | 0.78 | CHRM2 (0.42) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL760882 | 0.77 | KDM1A (0.41) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL6129709 | 0.75 | CHRM2 (0.40) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL63455 | 0.75 | CHRM2 (0.40) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL7999869 | 0.74 | ALDH1A1 (0.77) | KDM4EALDH1A1LMNAMAPTALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113728137-B | Aqueous solution of treating agent for synthetic fibers and method for producing synthetic fibers | 竹本油脂株式会社 | 2022-07-22 | — | — | CN | disclosed |
| CN-111607343-B | Conductive water-based pressure-sensitive adhesive and preparation method thereof | 上海宗特化工有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-111607343-A | Conductive water-based pressure-sensitive adhesive and preparation method thereof | 上海宗特化工有限公司 | 2020-09-01 | — | — | CN | disclosed |
| US-20150094463-A1 | HYDROXYALKYLATED POLYROTAXANE PRODUCTION METHOD | UBE INDUSTRIES, LTD. (JP) | 2015-04-02 | — | — | US | disclosed |
| EP-2832750-A1 | PROCESS FOR PRODUCING HYDROXYALKYLATED POLYROTAXANE | Ube Industries, Ltd. (JP) | 2015-02-04 | — | — | EP | disclosed |
| US-20090221816-A1 | Process for the Asymmetric Epoxidation of Olefins | LANXESS DEUTSCHLAND GMBH (DE) | 2009-09-03 | — | — | US | disclosed |
| US-7544819-B2 | Process for the asymmetric epoxidation of olefins | LANXESS DEUTSCHLAND GMBH (DE) | 2009-06-09 | — | — | US | disclosed |
| US-20050203303-A1 | Process for the asymmetric epoxidation of olefins | LANXESS DEUTSCHLAND GMBH (DE) | 2005-09-15 | — | — | US | disclosed |
| EP-1021426-B1 | CATALYTIC ASYMMETRIC EPOXIDATION | UNIV COLORADO STATE RES FOUND (US) | 2003-09-17 | — | — | EP | disclosed |
| US-6348608-B1 | ADDING OXIDIZING AGENT TO REACTION SOLUTION COMPRISING CHIRAL CYCLIC ENANTIOMERICALLY ENRICHED KETONE AND OLEFIN UNDER CONDITIONS EFFECTIVE TO GENERATE ENANTIOMERICALLY ENRICHED EPOXIDE, SEPARATING EPOXIDE FROM REACTION SOLUTION | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION | 2002-02-19 | — | — | US | disclosed |
| EP-1021426-A1 | CATALYTIC ASYMMETRIC EPOXIDATION | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2000-07-26 | — | — | EP | disclosed |
| EP-1021426-A4 | CATALYTIC ASYMMETRIC EPOXIDATION | UNIV COLORADO STATE RES FOUND (US) | 2000-07-26 | — | — | EP | disclosed |
| WO-1998015544-A1 | CATALYTIC ASYMMETRIC EPOXIDATION | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1998-04-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203303-A1 | Process for the asymmetric epoxidation of olefins | DUOX1, DUOX2, PPOX | CHRM2 4299/4885CHRM4 3307/4885CHRM5 3862/4885 |
| US-20090221816-A1 | Process for the Asymmetric Epoxidation of Olefins | DUOX1, DUOX2, PPOX | CHRM2 4299/4885CHRM4 3307/4885CHRM5 3862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.